Poster Abstract Session:
150. Urinary Tract Infection
Friday, October 5, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Adult ID, Epidemiology and Infection Control, Investigative ID, Pediatric ID


Presentations:
Comparative Effectiveness of Antibiotic Therapy for the Outpatient Treatment of Urinary Tract Infections Among Otherwise Healthy, Premenopausal Women
Anne M. Butler, PhD, MS; Matthew R. Keller, MA; Michael J. Durkin, MD MPH; Vikas R. Dharnidharka, MD, MPH; Margaret A. Olsen, PhD, MPH
Identifying Risk Factors for Recurrent Urinary Tract Infections among Female Outpatients
Brittany Morgan, MPH Candidate; Gregory B. Tallman, PharmD, MS; Miriam R. Elman, MPH, MS; David T. Bearden, PharmD; Jessina C. McGregor, PhD
No Benefit to Treating Male UTI for Longer than 7 Days: An Outpatient Database Study
George Germanos, MD; Barbara W. Trautner, MD, PhD, FIDSA; Roger Zoorob, MD, MPH; Dimitri M. Drekonja, MD, MS, FIDSA; Jason Salemi, PhD, MPH; Kalpana Gupta, MD, MPH; Larissa Grigoryan, MD PhD
Patient demographics and comorbidity profiles associated with hospitalized patients admitted with resistant vs. susceptible urinary tract infections (UTI): A multicenter analysis
Jon Bruss, MD, MSPH, MBA; David Melnick, MD; Akash Jain, PhD; John Murray, MPH; Ian Critchley, PhD; Stephen Kurtz, MS; Vikas Gupta, PharmD, BCPS
Association of Antibiotic Treatment Duration with First Recurrence of Uncomplicated Urinary Tract Infection in Pediatric Patients
Titilola M. Afolabi, PharmD, BCPS, BCPPS; Kellie J. Goodlet, PharmD, BCPS; Kathleen A. Fairman, MA
Posters
  • IDWeek poster 7-23-18.pdf (252.0 kB)
  • Urinary Tract Infections (UTIs) in the First Year Post-Renal Transplant: Risks and Opportunities
    Brian Bohn, PharmD; Vasilios Athans, PharmD, BCPS; Christopher Kovacs, MD; Brian Stephany, MD; Michael Spinner, PharmD
    Posters
  • ID week 2018 Bohn 1508.pdf (313.6 kB)
  • Clinical Significance of Staphylococcus aureus Bacteriuria
    Jennifer Masel, MD; Edwin Kamau, PhD; Dan Brooks, PhD; Todd Gleeson, MD
    Treatment of Asymptomatic Bacteriuria prior to Transcatheter Aortic Valve Replacement
    Alexandra Clay, BA; Kirthana R. Beaulac, PharmD; Gabriela M Andujar Vazquez, MD; Shira Doron, MD, MS, FIDSA; David Snydman, MD, FIDSA
    Posters
  • 1510_IDWPOSTER.pdf (313.5 kB)
  • Variation in Outpatient Urine Testing Practices for Uncomplicated Urinary Tract Infections
    Sonya Liu, BA; Jahnavi Bongu, MPH; Matthew Keller, MA; Anne M. Butler, PhD, MS; Margaret A. Olsen, PhD, MPH; Michael J Durkin, MD MPH
    Patient-based stratification of weighted-incidence syndromic antibiogram (WISCA) for empiric antibiotic prescribing
    Courtney Hebert, MD, MS; Erinn Hade, PhD; Protiva Rahman, BS; Mark Lustberg, MD, PhD; Courtney Dewart, RN, MPH; Preeti Pancholi, PhD; Kurt Stevenson, MD, MPH, FSHEA
    Evaluation of Antibiotic Prescribing Practices for Lower Urinary Tract Infections in the Emergency Department
    Megan Lim, PharmD; Lindsay Petty, MD; Nicholas Dillman, PharmD; Pamela Walker, PharmD; Jerod Nagel, PharmD, BCPS
    Management and Outcomes of Children with Extended-Spectrum Cephalosporin-Resistant Urinary Tract Infections (ESC-R UTIs)
    Marie Wang, MD, MPH; Tara Greenhow, MD; Vivian Lee, MD; Jimmy Beck, MD; Michael Bendel-Stenzel, MD; Nicole Hames, MD; Corrie McDaniel, DO; Erin King, MD; Whitney Sherry, MD; Deepika Parmar, MD; Sara Patrizi, DO; Nivedita Srinivas, MD; Alan Schroeder, MD
    Determining the Management of Children with Acute UTI/Pyelonephritis Who Do Not Fit Current Management Recommendations.
    Barry Scanlan, MB BAO BCh MCRI; Laila Ibrahim, MBBChBAO; Sandy Hopper, MBBS; Sarah McNab, PhD; Franz Babl, MD; Andrew Davidson, MBBS FRANZCA GradDipEd MD; Penelope Bryant, PhD
    Heterogeneity of Recent Phase 3 cUTI Clinical Trials with New Antibiotics
    Almasa Bass, PharmD; Roger Echols, MD, FIDSA; Simon Portsmouth, MD; Ann Howell, MS, PharmD
    Initial Clinical Response of Children with Extended-Spectrum Cephalosporin-Resistant Urinary Tract Infections (ESC-R UTI’s) Started on Discordant Antibiotics
    Marie Wang, MD, MPH; Vivian Lee, MD; Tara Greenhow, MD; Jimmy Beck, MD; Michael Bendel-Stenzel, MD; Nicole Hames, MD; Corrie McDaniel, DO; Erin King, MD; Whitney Sherry, MD; Deepika Parmar, MD; Sara Patrizi, DO; Nivedita Srinivas, MD; Alan Schroeder, MD
    Are Providers Shifting from NTF to Fosfomycin for Inpatient UTI? Big Data Reveals Small Shifts.
    Kalpana Gupta, MD, MPH; Matthew B. Goetz, MD; Makoto Jones, MD, MS; Judith M. Strymish, MD
    Posters
  • fosfonitroidsapdf.pdf (570.6 kB)
  • Oral Fosfomycin Use for Urinary Tract Infections and its Clinical Impact on Hospital Stay
    Christina Mai, MD; Henry Donaghy, MD; Thien-Ly Doan, PharmD
    A real world perspective on treatment of CRE UTIs with oral agents
    Ahmed Babiker, MBBS; Lloyd Clarke, B Sc (Hons); Ryan K. Shields, PharmD
    Posters
  • IDweek Doxy vs fosfo 09.26.pdf (130.2 kB)
  • De-implementation strategy to Reduce the Inappropriate use of urinary and intravenous CATheters: the RICAT-study
    Bart J. Laan, MD; Ingrid J. B. Spijkerman, MD, PhD; Mieke H. Godfried, MD, PhD; Berend C. Pasmooij, BSc; Marjon J. Borgert, PhD; Jolanda M. Maaskant, PhD; Brent C. Opmeer, PhD; Margreet C. Vos, MD, PhD; Suzanne E. Geerlings, MD, PhD

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.